Reich Kristian's Insider Trades & SAST Disclosures
Reich Kristian's most recent trade in MoonLake Immunotherapeutics - Ordinary Shares - Class A was a trade of 139,273 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 27, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Reich Kristian.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2025 | 139,273 | 139,273 | - | - | Stock Option (Right to Buy) | |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | 20 Jan 2025 | 111,949 | 153,930 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 20 Jan 2025 | 111,949 | 84,367 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | 20 Jan 2025 | 3,328 | 2,508 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 31,910 | 2,925,573 | - | 55 | 1,755,050 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Reich Kristian | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 29,491 | 2,957,483 | - | 55 | 1,622,005 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 29,431 | 70,071 | - | 55 | 1,618,705 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 27 Feb 2024 | 28,090 | 41,981 | - | 55 | 1,544,950 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 57.43 per share. | 20 Feb 2024 | 10,000 | 100,071 | - | 57.4 | 574,300 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Reich Kristian | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 57.45 per share. | 20 Feb 2024 | 10,000 | 2,987,483 | - | 57.5 | 574,500 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.30 per share. | 20 Feb 2024 | 569 | 99,502 | - | 55.3 | 31,466 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Reich Kristian | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 55.31 per share. | 20 Feb 2024 | 509 | 2,986,974 | - | 55.3 | 28,153 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 60.16 per share. | 14 Feb 2024 | 10,000 | 120,071 | - | 60.2 | 601,600 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Reich Kristian | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 62.43 per share. | 14 Feb 2024 | 10,000 | 130,071 | - | 62.4 | 624,300 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 14 Feb 2024 | 10,000 | 110,071 | - | 60.2 | 601,500 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Reich Kristian | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 60.15 per share. | 14 Feb 2024 | 10,000 | 2,997,483 | - | 60.2 | 601,500 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Reich Kristian | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 60.17 per share. | 14 Feb 2024 | 10,000 | 3,007,483 | - | 60.2 | 601,700 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 62.42 per share. | 14 Feb 2024 | 10,000 | 3,017,483 | - | 62.4 | 624,200 | Class A ordinary shares, par value $0.0001 per share |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | 05 Apr 2023 | 500,006 | 500,006 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2023 | 500,006 | 2,527,477 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | 05 Apr 2023 | 98,090 | 98,090 | - | - | Class A ordinary shares, par value $0.0001 per share | ||
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 05 Apr 2023 | 98,090 | 238,297 | - | - | Class C ordinary shares, par value $0.0001 per share | |
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | 05 Apr 2023 | 14,864 | 75,136 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG | ||
| MoonLake Immunotherapeutic... | Kristian Reich | Chief Scientific Officer | 05 Apr 2023 | 2,916 | 7,084 | - | - | Common shares, par value CHF 0.10 per share, of MoonLake AG |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges